Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
CARLSBAD, Calif., May 02, 2018 -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany, will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.
Mr. Massarany is scheduled to present on Wednesday, May 16 at 9:20 a.m. Pacific Time. Interested parties may access a live and archived webcast of the event at ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
[email protected]
